German biotech BioNTech today announced positive results from the primary analysis of a Phase II cohort evaluating German ...

The UK’S Medicines and Healthcare products Regulatory Agency (MHRA) has approved Swedish Orphan Biovitrum Tryngolza ...

German pharma Boehringer Ingelheim has handed full commercial and marketing rights for digital schizophrenia therapy CT-155 ...

Japanese drugmaker Daiichi Sankyo (TSE:4568) is deepening its push into AI-driven oncology, partnering with USA-based Imagene ...

Australian biotech Cartherics has expanded its partnership with US manufacturing specialist Catalent (NYSE: CTLT), securing ...

US clinical-stage biotech C4 Therapeutics (C4T) announced that it has entered into a new collaboration agreement with Roche to advance research in the emerging degrader-antibody conjugate (DAC) ...

Tempus AI , a technology company leading the adoption of AI to advance precision medicine, has announced an expanded, ...

USA-based neurodegenerative disorders specialist Annovis Bio today revealed that it has secured financing to support the ...

Pharma trade group Medicines Australia says that, along with its members, it supports free, fair, and open trade and firmly oppose the proposed introduction of 100% tariffs on Australian branded and ...

Shares of Indian drug major Sun Pharmaceutical Industries declined sharply in trade on the Bombay Stock Exchange, as investor sentiment turned cautious following reports of a potential large ...

Central and Eastern Europe has long been used by pharma companies as a lower-cost extension of Western operations. That role is changing. Poland, Hungary, and the Czech Republic are now used more ...

Northern Ireland based Galen has announced a new licensing partnership with Istituto Gentili, under which Galen’s subsidiary, POA Pharma Scandinavia, will become the sole distributor of Ozalin (2mg/ml ...